Melanoma patient follow-up study for multiple tumor stages
Part of Cancer, Skin clinical trials.
This study follows adults with certain melanoma stages to better understand the disease over time. You may be asked to share tissue samples (if available) so researchers can study tumor biology and track outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (age 18 or older)
- Your melanoma diagnosis was confirmed by pathology (histology exam)
- Your melanoma is either resectable stage II/III or advanced/unresectable stage III/IV (or unresectable primary)
- You have not had systemic (whole-body) treatment for the stage being studied (adjuvant-only may be allowed in some cases)
- You agree to join and sign the informed consent form
- You do not have choroid melanoma and you are not under legal guardianship/trusteeship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding or adjusting imaging scans during follow-up after melanoma surgery can help detect recurrence earlier. It compares different follow-up imaging schedules for people at higher risk after surgery.
This study follows people with high-risk uveal (eye) melanoma after their initial treatment to better understand relapse risk. It may help your care team track you more closely using scheduled visits and blood tests.
This trial studies how your immune system “profiles” change while you’re treated with immunotherapy for melanoma. Results may help doctors better understand who benefits from treatment and when.
This study looks at immune and tumor “behavior” markers in people with metastatic melanoma after standard treatment. It may help researchers understand why treatment works for some people and not others by testing blood and skin tumor samples.
This study looks at serial (repeated) tumour biopsies and blood samples in people with advanced melanoma. The goal is to understand biomarkers and disease changes over time, which may help improve future treatment decisions.
This study looks at how people with stage IV melanoma take part in research. It helps doctors understand what works best for patients like you.
Hear when a new Malignant Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.